Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

German Cancer Research Center Selects Contur ELN from Accelrys

Published: Friday, December 28, 2012
Last Updated: Friday, December 28, 2012
Bookmark and Share
The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) has licensed the server-based, on-premises version of Accelrys' Contur Electronic Lab Notebook (ELN).

Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced that the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) has licensed the server-based, on-premises version of the Contur Electronic Lab Notebook (ELN). The licensing agreement follows a successful two-month pilot program involving twenty chemists and biologists in four departments at DKFZ. When fully implemented, the Contur ELN will accelerate scientific innovation by improving collaboration, quality, efficiency and security for up to 1,000 researchers across the largest biomedical research institute in Germany.

"We wanted to deploy a single ELN across all scientific researchers to replace paper, facilitate information sharing and protect intellectual property," said Holger Haas, Head of the IT Department, DKFZ. "The single ELN system reduces cost of ownership while improving the management and reuse of information, as opposed to individual groups selecting and deploying different ELNs. Of all the ELNs we assessed, the Contur ELN was a clear leader because of its ease of use, its proven deployment track record and the excellent support we received from Accelrys during the pilot."

Along with increased competition for grants, academic researchers today face increasingly stringent data sharing and protection requirements, often imposed by funding organizations. Scientists also require a common research environment that supports distributed research teams and external partners while ensuring IP transparency, accountability and security.

"DKFZ's strategic decision reflects a growing trend in academic and research organizations today," said Mollie Hunter, Senior Vice President of Sales and Services at Accelrys. "In terms of rapid deployment, proven capabilities and bottom-line affordability, the Contur ELN is now well established as a valuable productivity tool for academic communities, offering proven performance for thousands of users. An ELN can pay for itself by preventing just one failed experiment or unnecessary repeated experiment."

Available as both a server-based, on-premises installation and as a software-as-a-service offering in the Cloud for Macs and PCs, the easy-to-deploy-and-use Contur ELN helps academic organizations meet the sophisticated requirements of today's research environment. In addition, the scalability of the Contur ELN accommodates the continually changing workflow and resourcing requirements encountered in academia.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,700+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ALMA Welcomes Accelrys as a Premium Sponsor
Association of Lab Managers (ALMA) now supported by leading lab software provider Accelrys
Friday, April 04, 2014
Dassault Systèmes and Accelrys to Join Forces
Delivering Scientific Innovation in the Age of Experience
Friday, January 31, 2014
Accelrys Acquires QUMAS
The acquisition extends Accelrys’ informatics portfolio with the addition of mission-critical, end-to-end document and process management compliance solutions.
Tuesday, December 10, 2013
Accelrys Advances Biology Innovation with New Release of Assay and Study Management Product Suite
Accelrys BioRails 4.5 and Accelrys Morphit 3.0 accelerate assay pipelines, improve cascade management and enhance collaborative decision-making in discovery biology.
Tuesday, November 19, 2013
Accelrys Receives Highest Rating in Gartner's Latest Laboratory Informatics System Report
Accelrys was the only vendor to achieve the highest possible rating in all five categories of new product development (NPD)
Friday, October 11, 2013
Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software
Cambridge Isotope Laboratories, Inc. is deploying the Accelrys Laboratory Execution System (LES) and three applications within the Accelrys Laboratory Information Management System.
Tuesday, September 10, 2013
Accelrys Acquires Environmental Health and Safety Leader ChemSW
Chemical inventory management solutions improve compliance and sustainability impact of Accelrys’ Scientific Innovation Lifecycle Management portfolio
Wednesday, September 04, 2013
Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software
Enterprise implementation follows successful pilot that achieved a 78 percent reduction in data review times and a 40 percent overall improvement in lab processing time
Sunday, September 01, 2013
The Evolution of the Integrated Platform: Accelrys' One-Two Punch
A look at how Accelrys is delivering an integrated platform of enterprise laboratory solutions.
Sunday, June 02, 2013
Accelrys and eMolecules Collaborate to Enhance Accelrys Available Chemicals Directory
Validated and curated in-stock compounds from eMolecules now accessible through Accelrys ACD
Saturday, April 06, 2013
Accelrys' Electronic Laboratory Notebooks Recognized in Gartner's Enterprise Category
Accelrys' electronic laboratory notebooks (ELN) as "very high" or "high" in each scientific and functional domain in a recent report by Gartner, Inc.
Sunday, March 03, 2013
Accelrys® ELN Delivers Seamless Integration with the Reaxys® Workflow Solution
New chemistry information management possibilities for research scientists arising from Accelrys' cooperation with Elsevier.
Sunday, March 03, 2013
Accelrys, Inc. Acquires Vialis AG
Accelrys Strengthens Leadership Position in Laboratory Informatics Market
Sunday, February 10, 2013
Accelrys Acquires Systems Integrator Vialis
Accelrys has acquired Vialis AG to solidify its market leadership in the laboratory informatics space
Sunday, January 20, 2013
Aquavit Pharmaceuticals forms Alliance Partnership with Accelrys
Aquavit to utilize Accelrys Enterprise Platform to develop advanced medical software
Sunday, November 11, 2012
Scientific News
Breaking Through the Barriers to Lab Innovation
Here we examine the drivers behind the move for greater innovation, the challenges and current trends in laboratory informatics, and the tools that can be used to break these barriers.
Education and Expense: The Barriers to Mass Spectrometry in Clinical Laboratories?
Here we examine the perceived barriers to mass spec in clinical laboratories and explore the possible drivers behind the recent shift in uptake of the technology in clinical settings.
Removing 62 Barriers to Pig–to–Human Organ Transplant in One Fell Swoop
The largest number of simultaneous gene edits ever accomplished in the genome could help bridge the gap between organ transplant scarcity and the countless patients who need them.
Fruit Fly Pheromone Flags Great Real Estate for Starting a Family
Finding could aid efforts to control mosquito-borne diseases like malaria by manipulating odorants
Gene Editing Could Enable Pig-To-Human Organ Transplant
The largest number of simultaneous gene edits ever accomplished in the genome could help bridge the gap between organ transplant scarcity and the countless patients who need them.
Antioxidants Cause Malignant Melanoma to Metastasize Faster
Fresh research at Sahlgrenska Academy has found that antioxidants can double the rate of melanoma metastasis in mice.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Biomarker Predicting Transplant Complications May be Key to Treating Them
A protein that can be used to predict if a stem cell transplant patient will suffer severe complications may also be the key to preventing those complications, an international research team based at the Indiana University School of Medicine reported Wednesday.
Potential New Diagnosis and Therapy for Breast Cancer
Scientists at the University of York, using clinical specimens from charity Breast Cancer Now’s Tissue Bank, have conducted new research into a specific sodium channel that indicates the presence of cancer cells and affects tumour growth rates.
First Results Describing Sick Sea Star Immune Response
Though millions of sea stars along the West Coast have perished in the past several years from an apparent wasting disease, scientists still don’t know why.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,700+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos